For following the competition: what moved in each program, several studies read as one move.
- Bemnifosbuvir-Ruzasvir
- peginterferon alfa-2a
- Ribavirin
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Hepatitis C, Chronic to watchlistEvery Monday by email · turn it off any timePro · free during the beta